Department of Dermatology, University of Florence, Florence, Italy.
Clin Exp Dermatol. 2009 Aug;34(6):688-93. doi: 10.1111/j.1365-2230.2008.03096.x. Epub 2009 Mar 14.
To evaluate the effectiveness of a silicone gel in treating surgical wounds compared with a control group of the same phenotype and same scar site for which a placebo was advised.
This was a randomized controlled trial, carried out in a dermatology department of a university hospital. In total, we studied 110 patients (55 men, 55 women) who had undergone outpatient surgery at the Department of Dermatology, University of Florence, between May and July 2005. The patients were divided into two groups: a treatment group (group A) and a control group (group B). Subjects (n = 65) in group A were prescribed silicone gel to be applied to the wound twice a day for 60 days after the removal of stitches. Subjects (n = 45) in group B were prescribed the use of zinc oxide cream. All subjects, in both study and control groups, were examined by the same dermatologists every month for 3 months after surgery, then every 2 months for a total follow-up of 8 months from the date of surgery.
In the treatment group, only 18 patients (27%) had formation of a nonphysiological scar: diastasic scar in 10 patients (15%), hypertrophic scar in 6 (9%) and atrophic scar in 2 (3%). No keloid scars were recorded. In the control group, 25 (55%) had an altered scar: keloid scars in 5 patients (11%), hypertrophic scar in 10 (22%), diastasic scar in 8 (18%) and atrophic scar in 2 (4%).
The results of this study indicate that silicone gel is able to reduce the formation of keloid and hypertrophic scars and the signs/symptoms associated with the healing process (paraesthesia, pulling sensation, alterations in colour).
评估硅凝胶治疗手术切口的效果,与建议使用安慰剂的同表型和同瘢痕部位的对照组进行比较。
这是一项随机对照试验,在一所大学医院的皮肤科进行。我们共研究了 2005 年 5 月至 7 月期间在佛罗伦萨大学皮肤科接受门诊手术的 110 名患者(55 名男性,55 名女性)。患者被分为两组:治疗组(A 组)和对照组(B 组)。A 组 65 名患者被开处硅凝胶,在拆线后 60 天内每天两次涂抹于伤口。B 组 45 名患者被开处氧化锌乳膏。两组所有患者在手术后 3 个月内每月由同一名皮肤科医生进行检查,然后每 2 个月进行一次随访,总随访时间从手术日期起 8 个月。
在治疗组中,只有 18 名患者(27%)形成了非生理性瘢痕:10 名患者(15%)为分裂性瘢痕,6 名患者(9%)为增生性瘢痕,2 名患者(3%)为萎缩性瘢痕。未记录到瘢痕疙瘩。在对照组中,25 名患者(55%)有改变的瘢痕:5 名患者(11%)为瘢痕疙瘩,10 名患者(22%)为增生性瘢痕,8 名患者(18%)为分裂性瘢痕,2 名患者(4%)为萎缩性瘢痕。
本研究结果表明,硅凝胶能够减少瘢痕疙瘩和增生性瘢痕的形成,以及与愈合过程相关的症状/体征(感觉异常、牵拉感、颜色改变)。